BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19915170)

  • 1. The use of baseline covariates in crossover studies.
    Kenward MG; Roger JH
    Biostatistics; 2010 Jan; 11(1):1-17. PubMed ID: 19915170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical testing of multiple endpoints in group-sequential trials.
    Glimm E; Maurer W; Bretz F
    Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The population risk as an explanatory variable in research synthesis of clinical trials.
    McIntosh MW
    Stat Med; 1996 Aug; 15(16):1713-28. PubMed ID: 8870154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical models for heart rate correction of the QT interval.
    Ring A
    Stat Med; 2010 Mar; 29(7-8):786-96. PubMed ID: 20213712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residuals and outliers in replicate design crossover studies.
    Schall R; Endrenyi L; Ring A
    J Biopharm Stat; 2010 Jul; 20(4):835-49. PubMed ID: 20496209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of two-stage test statistic in the two-period crossover trials.
    Wang SJ; Hung HM
    Biometrics; 1997 Sep; 53(3):1081-91. PubMed ID: 9333341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple analysis of crossover studies with one-group interaction.
    Cleophas TJ
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):322-7. PubMed ID: 7582382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change from baseline and analysis of covariance revisited.
    Senn S
    Stat Med; 2006 Dec; 25(24):4334-44. PubMed ID: 16921578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled nitric oxide and bronchial wall thickening in asthmatics during and after acute exacerbation: evidence of bronchial wall remodeling.
    Ketai L; Harkins M; Fiato KL; Iwamoto GK
    J Asthma; 2005 Oct; 42(8):667-71. PubMed ID: 16266958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global tests for combination drug studies in factorial trials.
    Hung HM
    Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On planning the number of controls in cross-sectional studies using previous studies: an application in occupational epidemiology.
    Wild P; Jovanovic B; Massin N
    J Epidemiol Biostat; 1999; 4(2):93-9. PubMed ID: 10619056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled carbon monoxide in asthmatic adults with bronchial reactivity: a prospective study.
    Pogson ZE; Antoniak MD; Mckeever TM; Lewis SA; Britton JR; Fogarty AW
    J Asthma; 2009 Sep; 46(7):665-9. PubMed ID: 19728202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical perspective on adjusting for center effect in a 2 x 2 crossover design with application to clinical trials.
    Yue LQ
    J Biopharm Stat; 2000 Nov; 10(4):559-71. PubMed ID: 11104393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N; Kronmal RA
    Contemp Clin Trials; 2005 Feb; 26(1):2-16. PubMed ID: 15837448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure.
    Tobin MD; Sheehan NA; Scurrah KJ; Burton PR
    Stat Med; 2005 Oct; 24(19):2911-35. PubMed ID: 16152135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small sample inference for fixed effects from restricted maximum likelihood.
    Kenward MG; Roger JH
    Biometrics; 1997 Sep; 53(3):983-97. PubMed ID: 9333350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.